全球 2DPA-1 市场规模、份额、成长分析，按应用（药品、农业化学品）、最终用途（医疗保健、纺织和染料）- 2024-2031 年行业预测

Global 2DPA-1 Market Size, Share, Growth Analysis, By Application(Pharmaceuticals, Agrochemicals), By End Use(Healthcare, Textile & Dye) - Industry Forecast 2024-2031

出版日期: 2024年04月02日 | 出版商:

SkyQuest | 英文 184 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球2DPA-1市场规模为6,176.1亿美元，预计将从2023年的6,410.8亿美元成长到2031年的8,639.5亿美元，在预测期（2024-2031年）复合年增长率为3.80%。

多功能化合物 DAPA 在药物合成、染料生产和各种工业製程中有着广泛的应用。 2DPA-1 是一种创新化合物，也称为 2-二苯乙酰基-1,3-茚满二酮，其全球市场以其独特的性能满足了这种合成化合物的多样化工业需求。为了满足不断增长的需求，全球 2DPA-1 市场专注于为广泛的应用提供这种化合物，主要作为製药、农业化学品和特种化学合成中的化学中间体。此外，它在染料、颜料和个人护理产品製造中发挥着至关重要的作用，其抗衰老、抗炎和抗氧化特性受到高度重视。不断扩大的全球 2DPA-1 市场为行业参与者提供了利润丰厚的机会，以满足多个行业对创新解决方案日益增长的需求。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 拉丁美洲其他地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- MEA 的其余部分

竞争格局

前 5 名玩家比较
2021 年关键参与者的市场定位
主要市场参与者所采取的策略
最佳制胜策略
近期市集活动
主要公司市占率（%），2021年

主要公司简介

Siemens AG (Germany)
GE Healthcare (United States)
Philips Healthcare (Netherlands)
Canon Medical Systems Corporation (Japan)
Hitachi, Ltd. (Japan)
Toshiba Medical Systems Corporation (Japan)
Koninklijke Philips NV (Netherlands)
Fujifilm Holdings Corporation (Japan)
Carestream Health, Inc. (United States)
Esaote SpA (Italy)
Samsung Medison Co., Ltd. (South Korea)
Hologic, Inc. (United States)
Mindray Medical International Limited (China)
Agfa-Gevaert NV (Belgium)
Shimadzu Corporation (Japan)
CurveBeam LLC (United States)
Planmed Oy (Finland)
Medtronic plc (Ireland)
Varian Medical Systems, Inc. (United States)
Epiroc AB (Sweden)
Elekta AB (Sweden)

简介目录

Product Code: SQMIG15E2176

Global 2DPA-1 Market size was valued at USD 617.61 billion in 2022 and is poised to grow from USD 641.08 billion in 2023 to USD 863.95 billion by 2031, growing at a CAGR of 3.80% during the forecast period (2024-2031).

The versatile compound DAPA finds extensive application in pharmaceutical synthesis, dye production, and various industrial processes. The global market for 2DPA-1, an innovative chemical compound also known as 2-diphenylacetyl-1,3-indandione, caters to the diverse industrial needs for this synthetic compound with its unique properties. Serving to meet the rising demand, the global 2DPA-1 market focuses on supplying this compound for a broad spectrum of applications, primarily as a chemical intermediate in pharmaceutical, agrochemical, and specialty chemical synthesis. Moreover, it plays a vital role in dye, pigment, and personal care product manufacturing, where its anti-aging, anti-inflammatory, and antioxidant features are highly valued. The expanding global 2DPA-1 market offers lucrative opportunities for industry players to meet the increasing demand for innovative solutions across multiple sectors.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global 2DPA-1 Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global 2DPA-1 Market Segmental Analysis

Global 2DPA-1 Market is segmented on the basis of application, end user and region. By application, the market is segmented into pharmaceuticals, agrochemicals, cosmetics, and others. By end user, the market is segmented into healthcare, textile & dye, others. By region, the market is divided into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global 2DPA-1 Market

The pharmaceutical sector tirelessly seeks fresh and inventive drug prospects to tackle diverse health issues. The distinctive therapeutic attributes of 2DPA-1, encompassing its anti-inflammatory, anti-cancer, and antiviral effects, propel its integration into drug exploration and advancement efforts, consequently fostering a substantial Compound Annual Growth Rate (CAGR) for the worldwide 2DPA-1 market throughout the projected timeframe.

Restraints in the Global 2DPA-1 Market

The arrival of new players in both regional and global markets has the potential to intensify competition, posing a significant threat to established entities. Enhanced product portfolios introduced by competitors can escalate the stakes for existing players, further heightening the competitive landscape.

Market Trends of the Global 2DPA-1 Market

The complexity and expense involved in producing 2DPA-1 could hinder its broad acceptance across industries, potentially restricting its market expansion. Elevated production costs might constrain the availability and affordability of 2DPA-1, thereby impeding its market growth and resulting in a comparatively lower Compound Annual Growth Rate (CAGR) for the global 2DPA-1 market in the projected timeframe.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global 2DPA-1 Market by Application

Market Overview
Pharmaceuticals
Agrochemicals
Cosmetics
Others

Global 2DPA-1 Market by End Use

Market Overview
Healthcare
Textile & Dye
Others

Global 2DPA-1 Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Siemens AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philips Healthcare (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Canon Medical Systems Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hitachi, Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Toshiba Medical Systems Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fujifilm Holdings Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Carestream Health, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Esaote SpA (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Samsung Medison Co., Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mindray Medical International Limited (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agfa-Gevaert NV (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shimadzu Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CurveBeam LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Planmed Oy (Finland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Varian Medical Systems, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Epiroc AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elekta AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments